Special Advertising Section
Acute Care Pharmaceuticals Armada Health Care Associates of Cape Cod, Inc. BD Diplomat Pharmacy, Inc. Equashield KeyCentrixTM Medi-Dose/EPS MHA Specialty Pharmacy Solutions Specialty Pharmacy Continuum Temptime Corporation
The profiles in this section were submitted and/or reviewed by the advertisers.
Acute Care Pharmaceuticals AT A GLANCE 12225 World Trade Drive D Ste. A San Diego, CA 92128 8 Website: www.Pharm ma-Choice.com Phone: (888) 909-77 700 Fax: (858) 675-9380 0
Product Line: Pharma-Choice™ Bra and Email: Info@acuteca areonline.com
Acute Care Pharmaceuticals has been servicing the healthcare industry for over 18 years by delivering exceptional products and services to healthcare providers nationwide. We offer a wide range of USP Chapter <797> and USP Chapter <800> compliant disposable products that are manufactured under the highest standards. All wipers are ISO Class 5 and USP <161> endotoxin limits for medical devices of 0.06 EU/mL. Our sterile alcohol is manufactured with USP grade water for injection and is available in a variety of sizes.
As a One-Stop Shop we can supply your facility with not only Sterile Alcohol and Wipers, but everything else your facility may need, including: Media Test Kits, Disinfectants, Apparel, Tacky Mats, Cleanroom Paper, Chemo Products, Sterile IV Seals and more. The quality manufacturing of Acute Care Pharmaceuticals’ PharmaChoice™ Brand of cleanroom disposables demonstrate our commitment to the future success of USP <797> and USP <800>. Acute Care Pharmaceuticals holds over 20 GPO and IDN Contracts and our products are used in, and trusted by, over 2,000 hospital systems nationwide. In addition, most of Acute Care Pharmaceuticals’ products are loaded and stocked at AmerisourceBergen, Cardinal and McKesson taking the hassle out of purchasing. If you want quality products and customer service that you can count on, call us today at 1.888.909.7700 for more information and your GPO contracted pricing.
Pharma-Hol Pharma-D Surface Disinfectant Pharma-Wipe Pharma-Sat Pharma-Surface Guard Pharma-Glove Pharma-Chemo Mat Pharma-Mop Covers Pharma-Mini Mop Covers Pharma-Mat Pharma-Notes Pharma-Paper Pharma-Coat Pharma-Cap Pharma-Shoe Cover
16
Corporate Profiles 2015
Special Advertising Section Specialty Pharmacy Continuum
Armada Health Care Armada Health Care Introduces ArmadaOne—A Comprehensive Specialty Pharmacy Technology Solution Developed for Today’s Complex Medication Needs The nation’s largest specialty pharmacy group purchasing organization (GPO) and channel management solutions provider, Armada Health Care, continues to be the leading supplier of manufacturer commercialization strategies and patient support services in the rapidly expanding specialty pharmacy marketplace.
A Devoted Focus Armada’s portfolio of offerings includes a full range of therapeutic categories, first-in-class specialty product contracting programs, hub services and innovative technology solutions. By offering this suite of services, Armada remains the only national contracting organization exclusively focused on specialty pharmaceutical programs.
Introducing ArmadaOne Recently, Armada introduced the ArmadaOne Specialty Pharmacy Workflow platform, a comprehensive new offering comprised of its existing suite of technology products along with several new patient modules. ArmadaOne works in conjunction with pharmacies’ existing dispensing systems and provides key functionalities to manage patients with complex therapeutic needs. ArmadaOne also offers users the ability to onboard specialty patients, streamline prior authorization management, connect with copay and patient assistance programs, and ongoing clinical consultation and compliance monitoring. Real-time data reporting enables pharma/biotech manufacturers, health plans and prescribers to measure results using the best data available and generate medication management and productivity reports.
AT A GLANCE
“Launching ArmadaOne was a natural evolution for our company and the convergence of several initiatives we have been working on for many years,” explained Lawrence Irene, RPh, co-founder and chief executive officer for Armada. “We understand the critical role technology plays when it comes to specialty pharmacy, and as a company at the epicenter of this industry, we are excited to launch ArmadaOne and deliver this new solution to the market.”
Expansion of Hub Services
100 Campus Drive e, Suite 300 Florham Park, NJ 07932 Phone: (973) 564--8004 Website: armadah healthcare.com
Products and d Services • Market accesss & commercializ zation • Comprehensive hub services • Integrated te echnology platforms • Data reportin ng & analytics
In addition to releasing ArmadaOne, Armada • Scalable pharmacy has continued to expand its hub services networks capabilities, by providing a complete solution • Therapy man nagement for patient support, reimbursement services systems and prescription intake/triage for dispensing pharmacies. “Whether for a complex orphan • GPO contracting programs product or a more broadly utilized medication, • Prior authorization support we understand the importance of putting the patient first while merging white-glove service • Annual speciialty pharmacy and real-time data reporting to our industry summit partners,” stated Arpan Patel, RPh, SVP, Clinical Services for Armada. “Via the intersection of our innovative technology platforms, URACaccredited call center, network of specialty pharmacy partners and high-touch support services, we ensure patients have access to products and initiate therapy in a timely manner for the medications they are prescribed.”
Unique Programs & Contracts As the specialty pharmacy market expands and Armada’s pharmacy membership grows, Armada continues to deliver significant value through unique manufacturer contracts and incentive programs for brand/generic pharmaceuticals, ancillary products and services.
Annual Specialty Pharmacy Summit For four days each May, Armada hosts the nation’s largest specialty pharmacy conference. Attendees gain an in-depth understanding of all aspects of specialty pharmacy from more than 125 renowned industry speakers who share the latest insights and trends impacting the industry. Nearly 100 hours of seminars, educational sessions and business workshops are offered at the Summit, along with vendor exhibits, expert panel discussions and a broad range of relevant business topics. Contact us today to learn more about how we can support your business at info@armadahealthcare.com.
Special Advertising Section Specialty Pharmacy Continuum
Corporate Profiles 2015
17
Associates of Cape Cod, Inc. AT A GLANCE Corporate Headqu uarters - USA Associates of Cape C Cod, Inc. 124 Bernard E. Saint Jean Drive East Falmouth, MA 0 02536-4445 Phone: (888) 395–AC CC1 (2221) or (508) 540–3444 Fax: (508) 540–8680 0 Website: www.acciussa.com
Germany Associates of Cape C Cod, Inc. European Subsidiary y PYROQUANT DIAGN NOSTIK GmbH Opelstrasse 14 64546 Mörfelden-Wa alldorf, Germany Phone: (49) 61 05–96 10 0 Fax: (49) 61 05–96 10 15 E-mail: service@acciiusa.de www.acciusa.de
Company Background Our corporate headquarters are located in East Falmouth, Mass., with offices in the UK and Germany. Founded in 1974, our company was the first to be licensed by the FDA to manufacture Limulus Amebocyte Lysate (LAL) for use as a quality control test for endotoxin detection in the pharmaceutical and medical device markets. Over the years, we have grown to be an internationally recognized leader in endotoxin detection, with more than 150 employees and a distribution network servicing 80 countries.
Products, Services & Capabilities
United Kingdom Associates of Cape C Cod Int’l., Inc. Deacon Park, Moorgate Road Knowsley, Liverpool L33 7RX United Kingdom m Phone: (44) 151–547–7444 Fax: (44) 151–547–74 400 E-mail: info@acciuk.co.uk www.acciuk.co.uk Company Registratio on Number: BR002906
18
Associates of Cape Cod, Inc. (ACC) is one of the world’s largest manufacturers of products developed to detect and quantify gram-negative bacterial endotoxins and (1Æ3)-β-D-glucans. Our products are used worldwide by leading pharmaceutical and medical device companies to ensure the safety of their parenteral drugs, biological products and medical devices.
Chromogenic Endotoxin Detection System Combining enhanced Pyrochrome® chromogenic reagent with the Pyros Kinetix® Flex Incubating Kinetic tube reader and Pyros® EQS Software, this system offers diverse options for conducting endotoxin testing. Pyrochrome is a versatile quantitative reagent for performing kinetic or endpoint assays. It is a sensitive and flexible reagent that can be used for testing in compliance with the United States Pharmacopeia, European Pharmacopeia, and Japanese Pharmacopeia bacterial endotoxins test chapter. Pyrochrome is offered
Corporate Profiles 2015
with either Pyrochrome Buffer or for endotoxin-specific testing, with Glucashield® Buffer. Pyrochrome can be used with the Pyros Kinetix® Flex tube reader at a 1:1 and economical 4:1 sample to LAL ratio.
Turbidimetric Endotoxin Testing using Pyrotelll®-T Pyrotell-T is used to quantify endotoxin in kinetic turbidimetric tests. Pyrotell-T can be used with the Pyros Kinetix® Flex tube reader and incubating microplate readers. When used with the Pyros Kinetix Flex tube reader, Pyrotell-T gives a highly economical, flexible and sensitive LAL assay. It can be used for a wide variety of endotoxin tests, ranging from standard water testing to samples requiring high sensitivity, such as intrathecal products and those requiring high dilutions to overcome interference.
Contract Testing Service (CTS) Our CTS laboratory was established more than 25 years ago to specialize in testing for endotoxin and glucan contamination and has the most extensive experience of any endotoxin and glucan testing laboratory in the world. CTS performs all LAL assay methods: gel-clot, chromogenic and turbidimetric, depending on client requirements.
Special Advertising Section Specialty Pharmacy Continuum
BD Since our founding in 1897, BD has sought to make healthcare more effective, efficient and safer through innovation in areas that leverage the company’s clinical knowledge and expertise. Our focus on Pharmacy builds on the company’s legacy and commitment to supporting safety and efficiency. Our expanded portfolio, including solutions from the recent acquisition of CareFusion, allows our customers to manage quality improvements, compounding legislation changes and drug shortages with cost-reduction expectations. BD’s comprehensive portfolio of medication management and preparation products as well as pharmacy disposal solutions is specifically designed to enhance patient and healthcare worker safety, improve efficiencies and help facilitate compliance to existing guidelines and standards.
Patient Safety Despite best efforts, patient safety can be compromised during medication preparation and delivery. BD’s broad, innovative portfolio can help. BD Cato™ Medication Workflow Solutions is an innovative gravimetric-based, barcode verification-enabled workflow solution that helps enhance safety and workflow efficiency of preparation of IV medications by detecting wrong drug and wrong dose errors in real time. BD Simplist™ Ready-to-Administer, Prefilled Injectables, supplied by BD Rx from its state-of-the-art pharmaceutical plant, are designed to improve patient care and safety by decreasing the number of steps in the traditional vial and syringe injection sequence,1 reducing the potential risk of medication error.
Healthcare Worker Safety OSHA reports that a hospital is one of the most hazardous places to work.2 BD offers solutions to help prevent occupational exposure. BD PhaSeal™ Closed System Drug Transfer Device (CSTD) is an airtight and leak-proof CSTD that mechanically prohibits the transfer of environmental contaminants into the system and the escape of drug or vapor concentrations outside the system, minimizing individual and environmental exposure to drug vapor aerosols and spills. The BD PhaSeal System has been clinically shown to reduce healthcare workers’ exposure to hazardous parenteral medications from preparation to administration to disposal.3 SmartSite® VialShield Chemo System is an intuitive needle-free system indicated for reconstitution or dispensing of medications, including chemotherapy agents. BD Disposal Solutions include collectors in a variety of colors and size specifically designed to safely contain Sharps, Non-hazardous Pharmaceutical, Chemotherapy and Hazardous RCRA waste.
Workflow Efficiency and Cost Containment As healthcare evolves, there will be increasing demand for better outcomes, while still controlling costs. Workflow efficiency will play a critical role in your success—and BD can help you get there, today. BD Cato™ Medication Workflow Solutions help improve efficiency and contain cost by standardizing the medication preparation workflow, automating documentation and help facilities optimize drug utilization to reduce drug waste. BD PhaSeal™ CSTDs prevent microbial ingress for up to 168 hours* (within an ISO Class V environment following aseptic technique),4-8 thus protecting the sterility of drug vials, which may facilitate drug vial optimization.9 Costly drugs that are still chemically stable may not have to be discarded after partial use, potentially leading to better drug utilization, lower overall cost of operations and reduced waste. The Chemo Safety System provides hospitals with a cost-effective solution to help protect healthcare workers from exposure to hazardous drugs. The system’s bonded Texium syringes and IV administration sets with no component assembly required, help to streamline workflow throughout the continuum of care. BD Simplist™ (see above).
Special Advertising Section Specialty Pharmacy Continuum
AT A GLANCE 1 Becton Drive Franklin Lakes, NJ J 07417 Phone: (201) 847-6800 Website: www.bd..com
Products Medical supplies, devices, laboratory instruments, antib bodies, reagents and diagnostic pro oducts
Vincent A. Forle enza Chairman, Chief Executive Officer and President
About BD
BD is a leading medical technology company that partners with customers and stakeholders to address many of the world’s most pressing and evolving health needs. Our innovative solutions are focused on improving medication management and patient safety; supporting infection prevention practices; equipping surgical and interventional procedures; improving drug delivery; aiding anesthesiology and respiratory care; advancing cellular research and applications; enhancing the diagnosis of infectious diseases and cancers; and supporting the management of diabetes.
About BD Rx Inc. BD Rx Inc. is a wholly-owned subsidiary of BD (Becton, Dickinson and Company). Based on a strategic decision and long-term investment in the acute care generic injectables category BD applied its expertise in manufacturing excellence, high-quality products and service delivery to the manufacturing of high-demand generic pharmaceuticals. This is a logical extension of BD’s demonstrated 12-year history of continuous, reliable supply of our Flush platform and existing leadership position in glass prefillable syringe manufacturing and should be seen as an addition to our current pharmaceutical offerings, as it will enable us to offer a broader range of treatment options for customers. With the BD Simplist™ ready-to-administer, prefilled injectables, BD Rx is aiming to redefine injectable drug administration practice. We envision safe patient care and efficient clinical applications and believe this is the future of injectables. For more information, please visit www.bdrxinc.com. BD, BD Logo and all other trademarks are property of Becton, Dickinson and Company. ©2015 BD. 07/15 MSS0649-1 BDRx0166-1 * Drug stability per manufacturers’ labeling.
References 1.
Potter P, Perry A, Stockert P, Hall A. Vial & Syringe Injection Steps. Basic Nursing, 7th ed. (St. Louis, MO: Mosby, 2010) 442-447.
2. United States Department of Labor. Occupational Safety and Health Administration (OSHA). “Safety and Health Topics.” https://www.osha.gov/SLTC/healthcarefacilities. 3. Wick C, Slawson MH, Jorgenson JA, et al. Using a closed-system protective device to reduce personnel exposure to antineoplastic agents. Am J HealthSyst Pharm. 2003;60(22):2314-2320. 4. McMichael D, Jefferson D, Carey E, et al. Utility of the PhaSeal closed system drug transfer device. Am J Pharm Benefits. 2011;3(1):9-16. 5. Carey ET, Forrey RA, Haughs D, et al. Second look at utilization of a closedsystem transfer device (BD PhaSeal). Am J Pharm Benefits. 2011;3(6):311-318. 6. Sanchez-Rubio J, Vargas B, Sanchez-Rubio L, et al. CSTDs and microbiological stability of cytostatics. Hosp Pharm Eur. 2013;69, July/August. 7. Wickham Laboratories Limited. Hampshire, UK. August 2013. Prevention of Microbial Ingress Into Vials and IV Bags Using the PhaSeal System. 8. Wickham Laboratories Limited. Hampshire, UK. Sept 2013. Microbial Integrity Testing (Whole Immersion) of BD PhaSeal Protectors. 9. Edwards MS, Solimando DA, Grollman FR, et al. Cost savings realized by use of the PhaSeal® closed-system transfer device for preparation of antineoplastic agents. J Oncol Pharm Pract. 2013;19(4):338-347.
Corporate Profiles 2015
19
Diplomat Pharmacy, Inc. Diplomat is the largest independent specialty pharmacy in the United States. We offer a broad range of innovative solutions to address the dispensing, 4100 S. Saginaw St. delivery, dosing and reimbursement of clinFlint, MI 48507 ically intensive, high-cost specialty drugs. Phone (toll-free): 877-977-9118 We see ourselves as a part of our patients’ Fax (toll-free): 800-5 550-6272 health care team. By working with payors, Website: http://diplo omat.is pharmaceutical manufacturers, physicians and retail/outpatient pharmacies, we deliver high-touch care that meets patients’ needs—as well as the needs of our teammates.
AT A GLANCE
When Diplomat opened its doors in 1975, it had one essential tenet: “Take good care of patients, and the rest falls into place.” Today, that tradition continues. For us, patients are not a number, nor are they their condition. At Diplomat, our mission is to blend clinical excellence with a personal touch—for happier lives and health that lasts.
Patient-centric Care We don’t stop working once the prescription is filled. At Diplomat, we focus on medication management programs for people in complex therapeutic categories—including oncology, immunology, hepatitis, multiple sclerosis, HIV, specialized infusion therapy and many other serious or long-term conditions. Through our Centers of Excellence, we provide comprehensive, patient-focused services, ensuring a superior standard of care. Services include assistance with complicated medication therapies, refill processing, side-effect management and adherence monitoring. An example of our innovative approach to helping patients achieve maximal adherence is Diplomat’s proprietary CarePak™. The medication CarePak™ provides patients with each day’s dose based on the prescriber’s written orders. We can customize the CarePak™ to accommodate nearly any patient need, making prescriptions that require combinations of treatments easier for patients to manage. Clinical studies even show that the CarePak™ improves the average duration of therapy.1 We pride ourselves on breaking down barriers to access medication for our patients. This includes securing prior authorizations for treatment. Our prior authorization (PA) success rate stands at 86%.2 In the event that a prior authorization request is denied, our appeals team is successful in 83% of cases.2 Once medications are approved, Diplomat’s dedicated funding team helps secure third-party support for patients in need. In 2014, we connected patients with over $55 million in copay assistance.3
A Flexible Teammate in Health Care We have grown our business in recent years by strengthening our clinical expertise in key therapeutic categories such as oncology and immunology. In addition to broadening the scope of our services, we continue to work at strengthening our relationships with patients, payors, pharmaceutical manufacturers and physicians. As a part of our calling to improve patient care, we also provide support services to a national network of retailers, independent pharmacy groups, hospitals and health systems.
Phil Hagerman, RPh, CEO and Chairman of Diplomat Pharmacy, Inc., in the company’s distribution center.
In this network, Diplomat contracts with retail and hospital outpatient pharmacies to offer specialty service programs. Through comprehensive back-end clinical services and care management, we enable our partners to meet the requirements of third-party payors to dispense specialty pharmaceuticals. This drives engagement for partnered pharmacies while maintaining the high-touch commitment that patients and clients have come to expect from us. Our position as an independent specialty pharmacy allows us to enter highly flexible relationships, so we can customize our offerings to our partners’ true needs.
Nationwide Network of Support With 18 locations, Diplomat provides specialty solutions from coast to coast—including Alaska, Hawaii and Puerto Rico. As of Dec. 31, 2014, our managed lives under contract stood at approximately 13 million. Since Dec. 2013, we have acquired American Homecare Federation, MedPro Rx, BioRx and Burman’s Specialty Pharmacy—three of which specialize in specialty infusion therapies. Burman’s, the exception among the four, specializes in hepatitis C treatment. Our repertoire of services—as well as our proactive engagement with pharmaceutical manufacturers early in their drug development process—has helped us build out our access to limited-distribution drugs. Through the changes in specialty pharmacy as the industry evolves, Diplomat is always ahead of the curve. While we’ve grown and expanded our services, we remain focused on service as it should be: one patient at a time.
References 1.
Abstract #55688. The effectiveness of CarePak: Adherence packaging in increasing lenalidomide therapy duration. Rice G, Nolan R, Grigorian M Diplomat Specialty Pharmacy, Flint, MI, USA. 2014.
2. Across all benefits investigations performed. Diplomat Prior Authorizations and Appeals, 2014. 3. Diplomat Funding Results, 2014.
20
Corporate Profiles 2015
Special Advertising Section Specialty Pharmacy Continuum
Equashield Hazardous drugs, such as chemotherapy antineoplastic agents, present an occupational hazard to those who handle them. Occupational exposure to hazardous drugs can lead to both acute and chronic effects, ranging from skin irritation to more serious reproductive complications and even some forms of cancer. The Centers for Disease Control and Prevention’s (CDC’s) National Institute for Occupational Safety and Health (NIOSH), the US Pharmacopeia (USP) Chapter <797>, the recently added USP Chapter <800>, the American Society of Health-System Pharmacists (ASHP), the International Society of Oncology Pharmacy Practitioners (ISOPP) and the Oncology Nursing Society (ONS) have all recognized and made recommendations to take additional measures based on the potential health risks associated with occupational exposure to hazardous drugs. While the dangers are often invisible to the naked eye, common practice when handling hazardous drugs creates multiple routes of exposure that can lead to contamination of the environment despite the use of standard personal protective equipment (PPE), Biological Safety Cabinets and associated handling procedures. Since hazardous drugs have adhesive characteristics, traces can often be carried out of the workspace, and are often found on unlikely surfaces such as keyboards, doorknobs and elevator buttons, outside of the designated areas for drug compounding and administration. NIOSH defines closed system transfer devices (CSTDs) as “a drug transfer device that mechanically prohibits the transfer of environmental contaminants into the system and the escape of hazardous drug or vapor concentrations outside the system,” and the FDA recently created the ONB category that clears devices as “closed antineoplastic and hazardous drug reconstitution and transfer system.” CSTDs, which typically encapsulate the syringe and vial into one closed system, provide a vital layer of protection against hazardous drug exposure. In fact, studies have shown that using a CSTD has significantly reduced the levels of surface contamination in labs, pharmacies and hospitals.1
However, not every CSTD provides the same level of protection, and not every CSTD is equally effective at closing off the major routes of exposure. Equashield’s closed systems are among the 99 Seaview Blvd. only CSTDs in the world cleared under the Port Washington, NY 11050 FDA’s ONB code, confirming that they meet the Phone: (516) 684-8200 Website: www.equ uashield.com requirements of a truly closed system. Equashield’s first- and second-generation systems are also the first to be substantiated to Products FDA and defined in FDA-cleared labeling as preEQUASHIELD® II - Closed System venting microbial ingress up to 7 days. Transfer Device Equashield’s system was created with a simpliFor medical inquirries related to fied, elegant design that provides ease of use, Equashield, contac ct Tammy Balzer, and covers more routes of exposure to hazardDirector of Clinica al Services USA ous drugs. tammyb@equashield.com One of the major routes of exposure, the syringe plunger, is uniquely covered by Equashield’s system. Studies show that a typical standard syringe plunger is contaminated many times after a drug transfer when it is drawn back out. When pharmacists use standard syringes, and even when they use standard syringes that are found in other closed systems, they can be exposed to hazardous drugs due to plunger contamination, and they risk major spills, as these plastic syringes can be pulled out of the barrel completely. Equashield’s flagship CSTD, EQUASHIELD® II, introduced in late 2013, uses a metal plunger instead of a standard plastic plunger. The metal rod runs through the center of the barrel, and is fully encapsulated and sealed in. This design prevents plunger contamination and it cannot be removed from the barrel, so it also prevents potential spills. The metal rod plunger cannot come in contact with the inner walls of the barrel, and therefore remains uncontaminated by the barrel sides. In this way, Equashield’s CSTD is the only CSTD to cover this major route of exposure by minimizing plunger contamination to undetectable levels.2 Equashield developed its fully encapsulated syringe system with an internal, self-contained pressure equalizer and sterile air chamber found within the syringe barrel. This feature allows for a more streamlined design that is intuitive for those using it in the compounding, transferring and administration of hazardous drugs. Equashield’s CSTD design also innovates with its connection mechanism. Whether connecting the syringe to a vial adapter, infusion bag or infusion tubing, each Equashield adapter and syringe are designed for safe and easy connections made in one smooth motion. Committed to protecting healthcare professionals, Equashield’s devices are qualified to the highest industry standards. Equashield’s CSTD is simple, with an elegant design and ease of use, which make it the CSTD of choice by hundreds of healthcare facilities in North America, Europe, Asia-Pacific and the Middle East. Equashield is a privately held medical device company with more than 140 employees. With offices located in Port Washington, N.Y., and its manufacturing facilities located internationally, the company has a growing global footprint, and is committed to continuing to protect healthcare professionals from exposure to hazardous drugs.
AT A GLANCE
References 1.
www.ncbi.nlm.nih.gov/pubmed/19965949.
2. http://opp.sagepub.com/content/early/2014/03/05/1078155214526428.full. pdf+html.
Special Advertising Section Specialty Pharmacy Continuum
Corporate Profiles 2015
21
KeyCentrix™ KeyCentrix™ is dedicated to the pharmacy industry by offering best-in-class technology, thought leadership, solutions consulting and hands-on support, ensuring our customers are equipped with solutions to advance pharmacy practice.
AT A GLANCE For more information about New Leaf Rx pharmacy so oftware or other KeyCentrix productss or services, please contact the K KeyCentrix team: 2420 N Woodlawn, B Bldg 500 Wichita, KS 67220 Phone: (800) 444-84 486 E-mail: info@keycentrix.com Website: Keycentrix..com
Social Media: https://www.faceboo ok.com/ KeyCentrix/ https://twitter.com/k keycentrix https://plus.google.c com/+Keycentrix/ posts https://www.linkedin n.com/company/ keycentrix-inc.
Beginning in 1973 KeyCentrix and its parent, Computer, Inc., have been supporting the industry with leading software solutions for over 40 years. Current KeyCentrix product offerings include RxKey® Pharmacy Software, flexTRAX Point of Sale and New Leaf Rx® Pharmacy Software. KeyCentrix technology and service solutions have been designed to transform pharmacy management by streamlining operations and providing the power of actionable data to make better decisions and grow profitably.
New Leaf Rx – Pharmacy Software for the Next Level of Patient Care Leverage the power of order-based, exceptiondriven workflow with New Leaf Rx by KeyCentrix. This unique combination enables custom configuration of your software to support ideal throughput and enforces best practices for single or multi-location pharmacy environments. New
Leaf Rx’s easy-to-use, fully customizable workflow and order manager are tailored for pharmacies and pharmaceutical manufacturers that are looking to innovate, increase efficiency and maximize their footprint in the specialty and more advanced high-margin pharmaceutical market. New Leaf Rx software, combined with our consultative and comprehensive implementation approach, offers pharmacies a level of resources and service unlike anything else available in the industry.
The New Leaf Rx Difference • Configurable Workflow Stages – Configurable workflow stages support your specific business needs and operations. Stages include: ° Data Entry ° Adjudication
° Dispensing ° PV2
° PV1 ° Scheduling
° Packing ° Will Call
• Order-Based Solution – New Leaf Rx’ order manager allows your pharmacy processing efficiencies by logically grouping prescriptions into orders based on patient, facility or prescriber. • Exception-driven Workflow – Ensure compliance adherence by requiring activities on complex therapies driven by: ° Manufacturer reporting ° Business objectives
° Disease state ° Lab values
° Stage validations ° Cost to patient
° Specific drugs ° Sales/marketing needs
• Consultative Implementation Approach - The KeyCentrix implementation team works with each customer to evaluate current and future state operations to ensure the most efficient configuration of the New Leaf Rx software for your specific business goals. In addition, a complete training curriculum is developed and implemented to ensure the pharmacy team is go-live ready, and onsite support during the first week provides an extra layer of assistance and confidence.
• External System Integrations – Through KeyCentrix’ consultative services, new and existing applications will be evaluated for replacement or integration, streamlining your operation and reducing long-term costs. The extensive list of current interfaces includes shipping interfaces with FedEx and UPS, as well as an integration with TherigySTM. • Data Extraction and Analysis – New Leaf Rx offers a powerful centralized reporting engine, as well as the ability to add custom fields specific to the needs of each location. Built on a SQL database, data can be easily extracted for reporting and compliance. • Document Management – Reduce errors and streamline the data entry process with document management. Faxes can be queued for fast processing of incoming prescriptions or quick storage of customer documents.
° Credit Review
22
Corporate Profiles 2015
Special Advertising Section Specialty Pharmacy Continuum
Medi-Dose/EPS For more than 40 years, the Medi-Dose System has been used by facilities of all sizes to package solid oral, unit-dose medications. With input from pharmacists and technicians, Medi-Dose has been designed to be the easiest, fastest and most cost-effective way to unit-dose and barcode your inventory. Medi-Dose began in 1971, when Milton Braverman, a former pharmaceutical company territory manager, formed his own company. Robert Braverman, President and Director of Marketing, remembers, “My dad was acutely aware of the requirements of hospital pharmacy. He saw the need for inexpensive, manual unit-dose packaging allowing hospitals to convert from traditional dispensing. He developed systems to package, handle and dispense predetermined amounts of medication so they would be accessible for one regular dose.” Although familiar today, launching the idea of unit dose was a huge problem the new company faced. “We were one of the pioneers, the innovators promoting unit dose in hospitals,” Robert Braverman recalled. “Due in part to Medi-Dose’s educational efforts, pharmacists and nurses accepted the validity of unit dose.” Inexpensive, Easy and Flexible: Because of its unique Cold-Seal technology, the Medi-Dose System is simple to use and requires no special in-service training or additional space. Medi-Cup blisters are available in a variety of sizes and styles to accommodate virtually any medication or storage system. Ultraviolet-inhibitant blisters provide additional protection from light. Plus, a combination of special blister plastics with aggressive tamper-evident label adhesives provides either six-month or one-year beyond-use dating for all your unit-dose packaging needs. • Sealed units can be left in sheets or easily torn down to individual doses.
• Medi-Cup Blisters are available in five sizes to accommodate the largest medications or the smallest storage spaces. • Lid-Label Covers are available in 8 1/2˝ × 11˝ laser sheets of 25 doses or 4˝ × 6 1/4˝ direct thermal sheets of five doses. • Laser Lid-Label Cover Sheets are available in 12 colors to facilitate color-coding of medications. • New Oval Blisters and Lid-Label Covers have been designed to fit your dispensing machines and storage cabinets. • All Medi-Cup Blisters and Lid-Label Covers work with our MILT 4 software, which can be used for all your barcoding and labeling needs. Adapts to Your Needs: With our new 64 bit– compatible MILT 4 software, you can design your labels any way you want (for solids, liquids, syringes, ampules, IVs—even equipment and supplies). In addition to the ability to use graphics, special fonts, tall man lettering, shapes— even logos and symbols—to better identify your medications, MILT 4 has been designed to easily create barcodes with the information that your barcode-enabled point-of-care and barcode medication administration systems require. Popular 1-D and 2-D barcode formats can be created with National Drug Code numbers, expiration dates, lot numbers and special codes.
AT A GLANCE 70 Industrial Drive e Ivyland, PA 18974 Phone: (800) 523--8966 Fax: (800) 323-89 966 Email: info@medid dose.com Website: www.medidose.com
Products Medi-Dose® (Solid d) and TampAlerT® (Liquid) Oral Unit-Dose Packaging Medi-Cup® PLUS packaging for extended beyond--use dating MILT® by Medi-Do ose unit-dose and bar-coding softwa are LiquiDose® labelin ng, IV additive and filtration productss Nultraviolet® ultraviolet light inhibitant bags Steri-Dropper sterrile ophthalmic dropper bottles High Alert and IV Line Tracing Labels Resealable bags, bottles and other pharmacy suppliess and disposables
To get started, all you will need is: 1. Medi-Cup Blisters: 13 styles to suit your packaging needs. 2. Lid-Label Covers: Laser or Direct Thermal labels to seal the blisters. 3. MILT 4 software: Design and manage Lid-Label Cover printing. 4. Fil-Form and Roll-E-ZY: Aligns Lid-Label Covers to the Medi-Cup Blisters and ensures a positive seal between labels and blisters. Inexpensive. Flexible. Tamper-Evident. If you are looking for a system to handle any or all of your unit-dose or barcoding needs, then the Medi-Dose System is a perfect fit for you!
Using our MILT 4 software, you can label and identify all your medication, complete with graphics and a bar code.
NEW 64 bit–compatible MILT 4 software. Medi-Dose is simple to use and requires no special in-service training.
Special Advertising Section Specialty Pharmacy Continuum
Corporate Profiles 2015
23
MHA Specialty Pharmacy Solutions AT A GLANCE 25-A Vreeland Road, Suite 200 Florham Park, NJ 07 7932 Phone: (800) 642-30 020 x 2940 Email: MHASpecialty y@mhainc.com Website: mhainc.com m
Collaborating with business partners and specialty pharmacies to capture, understand and act on data that help them drive patient engagement, adherence and persistence
The need for specialty medications is rising, and so is the need to create greater engagement with patients who could benefit from life-changing specialty therapies. What can drug manufacturers and specialty pharmacies do to cultivate patient engagement that leads to improved patient outcomes? One solution is to partner with an organization that has in-depth health care and clinical expertise, technological know-how and extensive analytics capabilities. A proven partner is Managed Health Care Associates, Inc. Specialty Pharmacy Solutions (MHA SPS). With MHA’s more than 25 years of experience with manufacturers and providers and an ever-expanding portfolio of technology-based solutions, MHA SPS is assisting business partners and specialty pharmacy members with generating deep data insights and analytics that lead to stronger patient adherence and persistence and contract compliance. “Our commitment is to provide commercial, clinical and technology solutions that deliver significant value for pharmaceutical and biotechnology companies and for specialty pharmacy members who are on the front lines engaging with patients every day,” said Erik Halstrom, Vice President, MHA SPS.
Solutions that Empower Patients and Deliver Broad Benefits MHA SPS creates strategic partnerships and develops and introduces new solutions that support specialty pharmacies in their goal to engage patients and optimize care. In doing so, patients benefit and so do other key stakeholders: • Pharmaceutical manufacturers gain actionable insights into deidentified patient data that more clearly demonstrates the value their therapies bring to patient outcomes. This data can also help manufacturers identify gaps in care, better understand adherence, provide insights into the competitive landscape and create innovative solutions for patients. • Specialty pharmacy members can access a broad selection of tools and resources created to help them engage with patients, identify and reduce barriers to treatment success, review therapy goals and treatment expectations, and provide patients with therapy-specific education and treatment support.
Deep Insights, Analytics to Support Adherence, Persistence and More In 2013, MHA SPS introduced Clinical Therapy Management (CTM), a powerful software application that tracks patient outcomes and interventions, measures adherence and persistence, and provides rich patient and treatment insights. The application also generates clinical reporting that meets the complex contracting needs of specialty pharmacy medications and helps elevate adherence. In fact, a recent study determined that implementation of the CTM program by a member specialty pharmacy enabled the pharmacy to achieve a significant positive impact on patient adherence. CTM provides a clinical support pathway to help specialty pharmacies
Contact Us Today The MHA SPS team is part of Managed Health Care Associates, Inc. (MHA), a leading health care services and technology company focused on the alternate site health care provider marketplace. To learn more about the services and solutions that help business partners and members maximize success, visit www. mhainc.com or contact 800.642.3020 x2940 or email us at MHASpecialty@mhainc.com.
24
Corporate Profiles 2015
engage with and clinically manage their patients. CTM is based upon identified pharmacy outreaches to the patient at key intervals within the patient’s treatment regimen, to provide timely therapy and disease state education and treatment support, including reviewing goals of therapy, treatment expectations and individualized patient counseling. This valuable application addresses a range of complex specialty therapeutics and provides a host of centralized tools for reporting essential clinical and dispensing metrics required by payers, manufacturers, accreditation and referral sources, and to manage patient care.
Streamlining the Prior Authorization Process In May 2015, MHA SPS launched a web-based prior authorization (PA) reporting platform for MHAuthorizeRx™ powered by CoverMyMeds, a leader in electronic PA solutions. MHAuthorizeRx automates the PA process and helps pharmacies fill prescriptions with improved efficiency. The addition of an exclusive reporting suite provides MHA pharmacy members with an easily accessible analytics platform to help drive visibility into their PA activities and trends. The streamlined information helps pharmacies navigate the complex ePA process and helps ensure patients receive the therapy they need faster.
Specialty Contracting Experience and Flexibility Specialty contracting is multi-faceted and heavily reliant on rich data and insights. As a leading health care services and technology company, MHA has a lengthy and strong track record of executing contracting strategies and data capture initiatives with pharmaceutical manufacturers. To create the most beneficial contracting agreement for the parties involved, MHA SPS goes to great lengths to understand the business needs and circumstances of both the manufacturer and the specialty pharmacy member. What data would help manufacturers deliver new and improved solutions for patients? What data are—or could be—captured by the pharmacy? What insights could evolve from that data and through patient engagement that occurs at the pharmacy? “Our unique perspective with our pharmacy members has allowed us to develop successful and beneficial contracting solutions with pharmaceutical companies for over two decades,” says John Campo, Vice President, Specialty Pharmacy Trade Relations & Contracting. “We are able to provide multiple levels of valuable information, including insights into complex disease states, such as hepatitis C, HIV and inflammatory conditions.”
Helping Partners and Members Navigate A Difficult Environment “The specialty landscape is complicated and perpetually evolving, and patients are originating and receiving ongoing treatment from within all of MHA’s alternate site health care membership,” Mr. Halstrom said. “Our Account team and Clinical Services colleagues are proven industry experts who are passionate about helping partners skillfully manage through this difficult environment and achieve success for their businesses and the patients they serve.”
Special Advertising Section Specialty Pharmacy Continuum
Specialty Pharmacy Continuum Specialty Pharmacy Continuum (SPC) is a dynamic addition to the Pharmacy Practice News editorial franchise, featuring essential clinical and business information for specialty pharmacies, home infusion providers, insurers and group purchasing organizations. Specialty pharmacy continues to experience explosive, double-digit growth, and for the past five years, SPC C has been tracking this trend and its effect on patients and providers. Topics covered over the course of our bimonthly print issues include biosimilars, site-of-care optimization strategies, drug adherence aids, best practices in home infusion and nutrition, and the use of cutting-edge technology to improve patient care. Our coverage also reflects the growing role that specialty pharmacists are playing in transitions of care, hence our focus on the entire patient-care continuum—from the hospital to the home and other community-based care settings.
Features SPC C includes a number of recurring features to meet the informational needs of our readers: Ask the Experts. One recent Q&A installment featured an interview with Mike Ellis, corporate vice president of Walgreens Specialty Pharmacy, on his personal and professional support of the Leukemia & Lymphoma Society’s “Light the Night” fundraising walks. Disease State Spotlight. Recent topics include psoriasis and psoriatic arthritis; and a two-part series on immune disorders, focusing on multiple sclerosis and rheumatoid arthritis. Practice Profiles. This feature includes in-depth examples of “best
Special Advertising Section Specialty Pharmacy Continuum
practices” in home infusion therapy, specialty pharmacy and other key patient care settings. Policy Update. Health care reform, REMS (Risk Evaluation and Mitigation Strategies), and Joint Commission compliance and accreditation are among the topics we track as needed.
Meeting Coverage
AT A GLANCE 545 W. 45th Stree et, 8th Floor New York, NY 100 036 Phone: (212) 957-5 5300 Fax: (212) 957-723 30 Website: www.spe ecialtypharmacycontinuum.com
SPC C editors and writers attend a wide range of conferences throughout the year, including the Armada Specialty Pharmacy Summit, MHA Annual Editorial Directo or Business Summit, and the National Association David Bronstein of Specialty Pharmacy’s Annual Meeting & Expo. davidb@mcmahon nmed.com These meetings primarily target established specialty Publication Dire ector pharmacy providers. However, we also help readers stay abreast of relatively new, nontraditional comDave Kaplan petitors in specialty pharmacy. Health systems are a dkaplan@mcmaho onmed.com prime example: Many of these entities are adding milSenior Editor lions of dollars in new revenue annually by expandMarie Rosenthal ing their specialty pharmacy offerings. Hence our mrosenthal@mcm mahonmed.com coverage of the American Society of Health-System Pharmacists’ Summer Meeting and Midyear Clinical Sales Account Manager Meetings, each of which included specialty pharmacy Lillie Onday topics in their 2015 programming. Londay@mcmahonmed.com We also welcome contributed articles, so if you are a clinical expert or operational whiz—regardless of which specialty pharmacy segment you represent—we’d like to hear from you. Send your topic ideas to davidb@mcmahonmed.com, and we will help you share your insights and lessons learned.
Corporate Profiles 2015
25
Temptime Corporation AT A GLANCE 116 The American Ro oad Morris Plains, NJ 079 950 Website: www.tempttimecorp.com Phone: (973) 630-60 051 Email: info@temptim mecorp.com
Stakeholders involved in the manufacture, distribution and reimbursement of specialty pharmaceuticals seek ways to increase support to patients while realizing cost advantages.
However, few integrate a simple tool into their processes that can help meet these objectives: • 7-fold return on investment for TransTracker® was reported due to reduced returns when TransTracker was included in every shipment to patients. • 50% reduction in call center time when TransTracker was used as a patient-facing decision-making tool to signal whether patients’ specialty medications experienced appropriate temperatures during transit. • 98% of patients surveyed want a temperature indicator to be included with specialty medications shipped to them.
The Temptime Difference—Expertise and Worldwide Leadership Temptime is the world’s leading provider of scientifically based time-temperature indicators that alert people if a product has been exposed to potentially damaging heat or freeze events. For nearly 30 years, our devices have helped healthcare workers confidently immunize millions of children around the world and extend care to regions previously thought to be unreachable. More than five billion of our time-temperature indicators have been used in 150 countries. Temptime is deeply committed to improving global public health. Founded in 1987, our scientists developed the first miniaturized technology to monitor temperature exposure of vials containing the oral polio vaccine. This device continues to be the only technology that meets the strict specifications of the world’s leading health organizations, including the World Health Organization, for distributing vaccines to developing countries. Today, pharmaceutical corporations, biotechnology companies and hospitals are using our devices to help improve storing and handling thousands of medical products that improve and save lives. It is our mission to monitor these products with 100 percent accuracy to ensure they have not been exposed to temperature events that could damage their effectiveness. We are honored to serve the world’s leading health organizations and contribute to improving the health of millions of people. We are dedicated to continually developing new technologies that will meaningfully improve global health for years to come.
TransTracker® Heat and Freeze Indicators for Secondary Packaging or Shipping Parcels TransTracker single-use, irreversible visual indicators monitor the temperature environment inside small and large parcels of temperature-sensitive products during shipping. • TransTracker F: visually shows when a specified maximum peak temperature threshold has been exceeded for a short duration of time. • TransTracker C: visually shows when a specified minimum lowtemperature threshold has been exceeded for a short duration of time. • TransTracker D: immediately shows when a specified maximum peak temperature threshold has been exceeded. • Multiple indicators can often be combined on a single TransTracker card to bracket both peak heat and low temperature thresholds.
LIMITmarker® Peak Heat Threshold Indicators • Single-use, irreversible threshold indicators that identify when a peak threshold heat excursion has been exceeded. • A range of indicators from 25°C to 50°C.
FREEZEmarker®—Freeze Indicators • Single-use indicators irreversibly change color from green to white to visually signal that a freeze event has occurred. • A range of indicators at –6°C, –1°C and 0°C.
Product Implementation Support— Seamless Integration Temptime reviews the packaging and shipping processes and procedures of our customers to develop a customized implementation plan that includes: • Packaging procedure review to support an optimal launch of the product • Process evaluation to integrate the application of the indicator • Work flow recommendations • Training of your sales and operations employees, and • Support in the design of user communication tools
Customized TransTracker Products 1. Branded: Integration of your logos, user instructions, and quality messages to include in shipments to your customers. 2. Temperature ranges: While we have a broad range of time and temperature monitoring capabilities, we can also work with you to develop custom indicators that meet your specific needs.
26
Corporate Profiles 2015
Special Advertising Section Specialty Pharmacy Continuum